Free tool
Healthcare stocks
We cover 1,880 companies in the Healthcare sector. The median market value in the group is $684.47M, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is +0.73%. 59% of the 963 with a 200-day average trade above it. Price change over the past year runs from −38.7% to +171.6% across the middle 80 percent of the group, with a median of +11.8%. Among those 1,000, 5 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,880 of 2,199 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| R1DY34.SA | Dr. Reddy's Laboratories Limited | $9.95B | Mid cap | −21.76% |
| PODD | Insulet Corporation | $9.92B | Mid cap | −56.52% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +67.40% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| AVTR | Avantor, Inc. | $9.75B | Mid cap | +9.16% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +85.10% |
| TWST | Twist Bioscience Corporation | $9.50B | Mid cap | +452.83% |
| WDH1.DE | Demant A/S | $9.39B | Mid cap | −5.53% |
| DEMANT.CO | Demant A/S | $9.37B | Mid cap | +17.33% |
| SYRE | Spyre Therapeutics, Inc. | $9.32B | Mid cap | +547.53% |
| KRK.WA | Krka, d. d. | $9.12B | Mid cap | +31.52% |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +100.62% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −10.74% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +182.02% |
| IMVT | Immunovant, Inc. | $8.95B | Mid cap | +192.14% |
| QIA.DE | Qiagen N.V. | $8.85B | Mid cap | −11.42% |
| HQY | HealthEquity, Inc. | $8.83B | Mid cap | +20.55% |
| 4523.T | Eisai Co., Ltd. | $8.67B | Mid cap | +9.74% |
| BRKR | Bruker Corporation | $8.66B | Mid cap | +64.93% |
| ATR | AptarGroup, Inc. | $8.57B | Mid cap | −2.35% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +3.09% |
| TGTX | TG Therapeutics, Inc. Common Stock | $8.48B | Mid cap | +96.32% |
| TXG | 10x Genomics, Inc. | $8.43B | Mid cap | +359.99% |
| ALKS | Alkermes plc | $8.26B | Mid cap | +69.69% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +14.26% |
| 6869.T | Sysmex Corporation | $7.42B | Mid cap | +5.65% |
| HIMS | Hims & Hers Health, Inc. | $7.41B | Mid cap | −26.15% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +62.22% |
| 2413.T | M3, Inc. | $7.39B | Mid cap | −20.12% |
| CAI | Caris Life Sciences, Inc. | $7.38B | Mid cap | −27.21% |
| RHC.AX | Ramsay Health Care Limited | $7.33B | Mid cap | +18.74% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +63.19% |
| ALK-B.CO | ALK-Abelló A/S | $7.23B | Mid cap | +8.24% |
| SHL.AX | Sonic Healthcare Limited | $7.20B | Mid cap | −11.60% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +19.61% |
| SRRK | Scholar Rock Holding Corporation | $7.09B | Mid cap | +74.77% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +21.56% |
| PACS | PACS Group, Inc. | $7.00B | Mid cap | +272.69% |
| CGON | CG Oncology, Inc. | $7.00B | Mid cap | +210.58% |
| 3391.T | Tsuruha Holdings Inc. | $6.89B | Mid cap | +8.33% |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | $6.82B | Mid cap | +13.26% |
| ORKA | Oruka Therapeutics, Inc. | $6.74B | Mid cap | +601.72% |
| 7747.T | Asahi Intecc Co., Ltd. | $6.68B | Mid cap | +58.61% |
| RADL3.SA | Raia Drogasil S.A. | $6.65B | Mid cap | +12.04% |
| E2XE34.SA | Exelixis, Inc. | $6.61B | Mid cap | +23.92% |
| HLUN-B.CO | H. Lundbeck A/S | $6.61B | Mid cap | +5.61% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +79.61% |
| HLUN-A.CO | H. Lundbeck A/S | $6.55B | Mid cap | +26.06% |
| BLTE | Belite Bio, Inc | $6.51B | Mid cap | +154.13% |
| 3088.T | MatsukiyoCocokara & Co. | $6.45B | Mid cap | −14.17% |
| COGT | Cogent Biosciences, Inc. | $6.39B | Mid cap | +212.13% |
| COH.AX | Cochlear Limited | $6.38B | Mid cap | −53.16% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +168.53% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +138.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.24B | Mid cap | +93.10% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.17B | Mid cap | +142.74% |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.72% |
| ERAS | Erasca, Inc. | $6.16B | Mid cap | +1016.98% |
| BLCO.TO | Bausch + Lomb Corporation | $6.15B | Mid cap | +18.08% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $6.13B | Mid cap | +49.03% |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +378.90% |
| STVN | Stevanato Group S.p.A. | $6.08B | Mid cap | +3.23% |
| TVTX | Travere Therapeutics, Inc. | $6.06B | Mid cap | +288.91% |
| CTEC.L | Convatec Group PLC | $6.06B | Mid cap | −2.30% |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +10.45% |
| DFTX | Definium Therapeutics, Inc. | $6.02B | Mid cap | +354.92% |
| T1FX34.SA | Teleflex Incorporated | $6.00B | Mid cap | +0.29% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +36.58% |
| TFX | Teleflex Incorporated | $5.94B | Mid cap | +10.85% |
| CRSP | CRISPR Therapeutics AG | $5.89B | Mid cap | +12.51% |
| XENE | Xenon Pharmaceuticals Inc. | $5.85B | Mid cap | +58.42% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −19.07% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.62B | Mid cap | +77.42% |
| MMED | MiniMed Group, Inc. | $5.60B | Mid cap | +2.33% |
| SHC | Sotera Health Company | $5.57B | Mid cap | +19.04% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | +3.32% |
| GRFS | Grifols, S.A. | $5.44B | Mid cap | −17.62% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.23B | Mid cap | +20.73% |
| HAE | Haemonetics Corporation | $4.93B | Mid cap | +96.13% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +102.62% |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | $4.89B | Mid cap | −14.48% |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +209.16% |
| BLLN | BillionToOne, Inc. | $4.72B | Mid cap | −8.14% |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +127.83% |
| 000100.KS | Yuhan Corporation | $4.67B | Mid cap | −25.59% |
| WAY | Waystar Holding Corp. | $4.64B | Mid cap | −32.56% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.63B | Mid cap | −11.37% |
| ICUI | ICU Medical, Inc. | $4.56B | Mid cap | +44.85% |
| OBCK.DE | Ottobock SE & Co. KGaA I | $4.51B | Mid cap | −0.82% |
| DOCS | Doximity, Inc. | $4.51B | Mid cap | −62.74% |
| RLAY | Relay Therapeutics, Inc. | $4.51B | Mid cap | +486.04% |
| ELVN | Enliven Therapeutics, Inc. | $4.48B | Mid cap | +205.89% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.47B | Mid cap | +80.49% |
| CELC | Celcuity Inc. | $4.44B | Mid cap | +87.35% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +49.74% |
| NVST | Envista Holdings Corporation | $4.39B | Mid cap | +30.07% |
| LIVN | LivaNova PLC | $4.37B | Mid cap | +40.92% |
| HTFL | Heartflow, Inc. | $4.34B | Mid cap | +67.19% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.26% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.24B | Mid cap | +49.81% |
| ADPT | Adaptive Biotechnologies Corporation | $4.19B | Mid cap | +107.18% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.17B | Mid cap | +340.71% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +22.31% |
| 4506.T | Sumitomo Pharma Co., Ltd. | $4.16B | Mid cap | −2.73% |
| LEGN | Legend Biotech Corporation | $4.14B | Mid cap | −38.44% |
| TNGX | Tango Therapeutics, Inc. | $4.13B | Mid cap | +264.73% |
| MANE | Veradermics, Incorporated | $4.11B | Mid cap | +171.13% |
| IDYA | IDEAYA Biosciences, Inc. | $4.10B | Mid cap | +71.91% |
| IRTC | iRhythm Holdings, Inc. | $4.06B | Mid cap | −25.71% |
| ABCL | AbCellera Biologics Inc. | $4.05B | Mid cap | +195.51% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.04B | Mid cap | −0.90% |
| RCUS | Arcus Biosciences, Inc. | $4.02B | Mid cap | +211.03% |
| VKTX | Viking Therapeutics, Inc. | $3.99B | Mid cap | +32.19% |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +60.12% |
| TLX | Telix Pharmaceuticals Limited | $3.96B | Mid cap | −4.26% |
| MCOV-B.ST | Medicover AB (publ) | $3.91B | Mid cap | −10.12% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.91B | Mid cap | −12.72% |
| BBZA.DE | BB Biotech AG | $3.90B | Mid cap | +7.22% |
| 000105.KS | Yuhan Corporation | $3.88B | Mid cap | −31.05% |
| CAMX.ST | Camurus AB (publ) | $3.87B | Mid cap | −14.52% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +52.72% |
| FIE.DE | Fielmann Group AG | $3.85B | Mid cap | −30.39% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.82B | Mid cap | +233.60% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.80B | Mid cap | +22.85% |
| 7459.T | MediPal Holdings Corporation | $3.77B | Mid cap | +14.74% |
| GRAL | GRAIL, Inc. | $3.69B | Mid cap | +150.69% |
| OGN | Organon & Co. | $3.61B | Mid cap | +52.78% |
| A2LC34.SA | Alcon Inc. | $3.57B | Mid cap | −12.91% |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +168.82% |
| QURE | uniQure N.V. | $3.54B | Mid cap | +228.30% |
| OPCH | Option Care Health, Inc. | $3.54B | Mid cap | −15.75% |
| VCYT | Veracyte, Inc. Common Stock | $3.54B | Mid cap | +49.04% |
| NHC | National HealthCare Corporation | $3.52B | Mid cap | +103.48% |
| PLSE | Pulse Biosciences, Inc. | $3.50B | Mid cap | +197.94% |
| ZEAL.CO | Zealand Pharma A/S | $3.48B | Mid cap | −27.05% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +196.22% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.33B | Mid cap | +275.00% |
| MBX | MBX Biosciences, Inc. | $3.30B | Mid cap | +394.02% |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.27B | Mid cap | −27.10% |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +10.69% |
| AFX.DE | Carl Zeiss Meditec AG | $3.26B | Mid cap | −23.23% |
| WRBY | Warby Parker Inc. | $3.24B | Mid cap | −0.61% |
| BIOA-B.ST | BioArctic AB (publ) | $3.24B | Mid cap | +20.03% |
| CLDX | Celldex Therapeutics, Inc. | $3.24B | Mid cap | +87.96% |
| TMDX | TransMedics Group, Inc. | $3.23B | Mid cap | −18.59% |
| VIRP.PA | Virbac SA | $3.22B | Mid cap | −2.81% |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +88.75% |
| AMBU-B.CO | Ambu A/S | $3.20B | Mid cap | −19.61% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.20B | Mid cap | +26.21% |
| 7649.T | Sugi Holdings Co.,Ltd. | $3.19B | Mid cap | −28.33% |
| IRON | Disc Medicine, Inc. | $3.16B | Mid cap | +38.71% |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +58.44% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $3.03B | Mid cap | −22.60% |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.08% |
| ALMS | Alumis Inc. | $2.98B | Mid cap | +388.98% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +82.91% |
| ZLAB | Zai Lab Limited | $2.94B | Mid cap | −23.10% |
| BKD | Brookdale Senior Living Inc. | $2.91B | Mid cap | +59.90% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.89B | Mid cap | +637.70% |
| ALHC | Alignment Healthcare, Inc. | $2.82B | Mid cap | −12.77% |
| ACHC | Acadia Healthcare Company, Inc. | $2.78B | Mid cap | +34.73% |
| 9989.T | Sundrug Co.,Ltd. | $2.76B | Mid cap | −17.00% |
| RGC | Regencell Bioscience Holdings Limited | $2.74B | Mid cap | −54.89% |
| VRDN | Viridian Therapeutics, Inc. | $2.74B | Mid cap | +30.21% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +56.96% |
| NRIX | Nurix Therapeutics, Inc. | $2.73B | Mid cap | +178.70% |
| EBO.AX | EBOS Group Limited | $2.72B | Mid cap | −35.38% |
| PRVA | Privia Health Group, Inc. | $2.71B | Mid cap | −0.93% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +237.59% |
| CDNA | CareDx, Inc. | $2.63B | Mid cap | +298.43% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.62B | Mid cap | +2.09% |
| PHVS | Pharvaris N.V. | $2.62B | Mid cap | +57.76% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −9.60% |
| WGS | GeneDx Holdings Corp. | $2.61B | Mid cap | −28.28% |
| B72.DE | AtaiBeckley Inc. | $2.60B | Mid cap | +57.16% |
| CURA.TO | Curaleaf Holdings, Inc. | $2.60B | Mid cap | +225.42% |
| EMEIS.PA | EMEIS | $2.60B | Mid cap | +10.18% |
| PGEN | Precigen, Inc. | $2.60B | Mid cap | +82.91% |
| BV3.DE | BAVARIAN NORDIC N | $2.59B | Mid cap | +14.47% |
| BAVA.CO | Bavarian Nordic A/S | $2.58B | Mid cap | −10.13% |
| 2784.T | Alfresa Holdings Corporation | $2.57B | Mid cap | +7.97% |
| TRVI | Trevi Therapeutics, Inc. | $2.56B | Mid cap | +146.57% |
| VERA | Vera Therapeutics, Inc. | $2.54B | Mid cap | +65.32% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +107.86% |
| BHC.TO | Bausch Health Companies Inc. | $2.52B | Mid cap | −8.00% |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +176.20% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +17.16% |
| BHC | Bausch Health Companies Inc. | $2.50B | Mid cap | −7.81% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.50B | Mid cap | +6.99% |
| NUVB | Nuvation Bio Inc. | $2.49B | Mid cap | +146.53% |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +316.68% |
| ATRC | AtriCure, Inc. | $2.48B | Mid cap | +28.65% |
| PBH | Prestige Consumer Healthcare Inc. | $2.46B | Mid cap | −21.64% |
| RAPP | Rapport Therapeutics, Inc. | $2.46B | Mid cap | +249.76% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.44B | Mid cap | +63.50% |
| ONT.L | Oxford Nanopore Technologies plc | $2.44B | Mid cap | −14.60% |
| DMP.DE | Dermapharm Holding SE | $2.43B | Mid cap | +14.86% |
| BFLY | Butterfly Network, Inc. | $2.41B | Mid cap | +483.23% |
| OCUL | Ocular Therapeutix, Inc. | $2.39B | Mid cap | −8.34% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +42.20% |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +37.69% |
| MLYS | Mineralys Therapeutics, Inc. | $2.32B | Mid cap | +78.70% |
| 009420.KS | Hanall Biopharma Co., Ltd. | $2.32B | Mid cap | +108.57% |
| COAG | Hemab Therapeutics Holdings, Inc. | $2.32B | Mid cap | +46.03% |
| ALMR | Alamar Biosciences, Inc. | $2.29B | Mid cap | +50.09% |
| GENB | Generate Biomedicines, Inc. | $2.27B | Mid cap | +61.11% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.27B | Mid cap | +4.09% |
| URGN | UroGen Pharma Ltd. | $2.27B | Mid cap | +150.59% |
| EKTA-B.ST | Elekta AB (publ) | $2.27B | Mid cap | +19.21% |
| ADUS | Addus HomeCare Corporation | $2.26B | Mid cap | +3.81% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.26B | Mid cap | +10.13% |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | −3.82% |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +9.42% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.23B | Mid cap | +38.03% |
| VCEL | Vericel Corporation | $2.21B | Mid cap | +20.76% |
| ZBIO | Zenas BioPharma, Inc. | $2.20B | Mid cap | +103.93% |
| CLOV | Clover Health Investments, Corp. | $2.19B | Mid cap | +56.14% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +58.21% |
| XRAY | DENTSPLY SIRONA Inc. | $2.19B | Mid cap | −21.70% |
| NEO | NeoGenomics, Inc. | $2.19B | Mid cap | +160.31% |
| XNCR | Xencor, Inc. Common Stock | $2.18B | Mid cap | +265.79% |
| EXE.TO | Extendicare Inc. | $2.18B | Mid cap | +147.28% |
| BHVN | Biohaven Ltd. | $2.17B | Mid cap | −3.75% |
| 9987.T | Suzuken Co., Ltd. | $2.17B | Mid cap | −11.16% |
| STOK | Stoke Therapeutics, Inc. | $2.16B | Mid cap | +77.32% |
| CLOV34.SA | Clover Health Investments, Corp. | $2.15B | Mid cap | +44.32% |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +77.45% |
| GN.CO | GN Store Nord A/S | $2.15B | Mid cap | −19.72% |
| KLRA | Kailera Therapeutics, Inc. | $2.14B | Mid cap | −31.73% |
| ADMA | ADMA Biologics, Inc. | $2.14B | Mid cap | −42.86% |
| PVLA | Palvella Therapeutics, Inc. | $2.14B | Mid cap | +195.71% |
| 302440.KS | SK bioscience Co.,Ltd. | $2.13B | Mid cap | −22.23% |
| HCM | HUTCHMED (China) Limited | $2.13B | Mid cap | −23.04% |
| HCM.L | HUTCHMED (China) Limited | $2.12B | Mid cap | −21.24% |
| NANO.PA | Nanobiotix S.A. | $2.12B | Mid cap | +341.09% |
| NBTX | Nanobiotix S.A. | $2.11B | Mid cap | +321.42% |
| ALIF-B.ST | AddLife AB (publ) | $2.09B | Mid cap | −7.56% |
| GNS.L | Genus plc | $2.08B | Mid cap | −13.32% |
| NEU.AX | Neuren Pharmaceuticals Limited | $2.08B | Mid cap | +18.47% |
| PIII | P3 Health Partners Inc. | $2.06B | Mid cap | +35.72% |
| CMPS | COMPASS Pathways plc | $2.06B | Mid cap | +224.89% |
| NVCR | NovoCure Limited | $2.05B | Mid cap | +50.60% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +26.87% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +78.59% |
| TSHA | Taysha Gene Therapies, Inc. | $2.02B | Mid cap | +112.33% |
| PRGO | Perrigo Company plc | $2.01B | Mid cap | −36.97% |
| EMBLA.CO | Embla Medical hf | $2.00B | Mid cap | −5.76% |
| SRPT | Sarepta Therapeutics, Inc. | $2.00B | Small cap | +4.76% |
| GHRS | GH Research PLC | $1.99B | Small cap | +119.42% |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +9.98% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | $1.98B | Small cap | −2.43% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.97B | Small cap | +8.44% |
| SNDA | Sonida Senior Living, Inc. | $1.97B | Small cap | +57.21% |
| FLRY3.SA | Fleury S.A. | $1.97B | Small cap | +39.13% |
| ZYME | Zymeworks Inc. | $1.96B | Small cap | +88.54% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $1.95B | Small cap | −9.02% |
| LKFT | Lakefront Biotherapeutics NV | $1.94B | Small cap | −5.53% |
| SEPN | Septerna, Inc. | $1.93B | Small cap | +245.32% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +14.76% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.91B | Small cap | −26.29% |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +18.72% |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +800.59% |
| GXE.DE | Lakefront Biotherapeutics NV | $1.89B | Small cap | −44.50% |
| ALVO-SDB.ST | Alvotech SDB | $1.87B | Small cap | −34.75% |
| ASTH | Astrana Health, Inc. | $1.87B | Small cap | +25.66% |
| PSNL | Personalis, Inc. | $1.84B | Small cap | +267.02% |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −39.02% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.11% |
| VIR | Vir Biotechnology, Inc. | $1.81B | Small cap | +144.52% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +390.10% |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −18.51% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | $1.81B | Small cap | +52.14% |
| ETON | Eton Pharmaceuticals, Inc. | $1.80B | Small cap | +268.93% |
| ALVO | Alvotech | $1.80B | Small cap | −39.30% |
| 4540.T | Tsumura & Co. | $1.78B | Small cap | +9.38% |
| INSP | Inspire Medical Systems, Inc. | $1.77B | Small cap | −34.28% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +27.20% |
| ATT.ST | Attendo AB (publ) | $1.76B | Small cap | +75.11% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.74B | Small cap | −16.24% |
| FTRE | Fortrea Holdings Inc. | $1.74B | Small cap | +106.21% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +335.60% |
| AVLN | Avalyn Pharma Inc. | $1.69B | Small cap | +29.54% |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +128.55% |
| 7716.T | Nakanishi Inc. | $1.68B | Small cap | +55.31% |
| CLARI.PA | Clariane SE | $1.67B | Small cap | −7.85% |
| SIA.TO | Sienna Senior Living Inc. | $1.65B | Small cap | +25.31% |
| ABSI | Absci Corporation | $1.65B | Small cap | +279.13% |
| 4DX.AX | 4DMedical Limited | $1.65B | Small cap | +652.94% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +580.25% |
| BCAX | Bicara Therapeutics Inc. | $1.63B | Small cap | +117.14% |
| 8129.T | Toho Holdings Co., Ltd. | $1.62B | Small cap | −22.82% |
| 8086.T | Nipro Corporation | $1.62B | Small cap | +6.42% |
| AGL | agilon health, inc. | $1.61B | Small cap | +178.58% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.61B | Small cap | +137.42% |
| ARDT | Ardent Health, Inc. | $1.59B | Small cap | −10.95% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.59B | Small cap | +12.48% |
| TYRA | Tyra Biosciences, Inc. | $1.59B | Small cap | +122.42% |
| OMCL | Omnicell, Inc. | $1.58B | Small cap | +0.39% |
| KMTS | Kestra Medical Technologies, Ltd. | $1.58B | Small cap | +51.92% |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +48.10% |
| LBRX | LB Pharmaceuticals Inc | $1.57B | Small cap | +182.08% |
| AAPG | Ascentage Pharma Group Internat | $1.57B | Small cap | −61.38% |
| NVAX | Novavax, Inc. | $1.56B | Small cap | +25.53% |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.55B | Small cap | −25.64% |
| AVBP | ArriVent BioPharma, Inc. | $1.55B | Small cap | +62.02% |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.53% |
| CNMD | CONMED Corporation | $1.53B | Small cap | −5.45% |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.14% |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.53B | Small cap | +18.84% |
| 6849.T | Nihon Kohden Corporation | $1.53B | Small cap | −5.62% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.51B | Small cap | +301.52% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.50B | Small cap | +83.48% |
| SDGR | Schrödinger, Inc. | $1.50B | Small cap | +2.30% |
| REPL | Replimune Group, Inc. | $1.49B | Small cap | +187.80% |
| AKTS | Aktis Oncology, Inc. | $1.48B | Small cap | +19.15% |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +197.55% |
| PYC.AX | PYC Therapeutics Limited | $1.48B | Small cap | +63.71% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +200.39% |
| AMBEA.ST | Ambea AB (publ) | $1.48B | Small cap | +32.95% |
| NOLA-B.ST | Nolato AB (publ) | $1.48B | Small cap | −8.30% |
| ENOV | Enovis Corporation | $1.48B | Small cap | −17.46% |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +14.00% |
| PAHC | Phibro Animal Health Corporation | $1.46B | Small cap | +13.43% |
| RDC.DE | Redcare Pharmacy NV | $1.46B | Small cap | −31.39% |
| AZTA | Azenta, Inc. | $1.45B | Small cap | +7.96% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +107.85% |
| ATEC | Alphatec Holdings, Inc. | $1.43B | Small cap | −41.10% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +96.83% |
| ANRO | Alto Neuroscience, Inc. | $1.42B | Small cap | +821.57% |
| GDS.PA | Ramsay Générale de Santé SA | $1.41B | Small cap | +11.00% |
| 4483.T | JMDC Inc. | $1.41B | Small cap | −18.41% |
| 3148.T | Create SD Holdings Co., Ltd. | $1.40B | Small cap | +3.09% |
| OMER | Omeros Corporation | $1.40B | Small cap | +343.22% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.40B | Small cap | +43.76% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +176.46% |
| F9L.F | Joincare Pharmaceutical Group Industry Co.,Ltd. | $1.39B | Small cap | −48.41% |
| 9627.T | Ain Holdings Inc. | $1.38B | Small cap | +4.41% |
| 3360.T | Ship Healthcare Holdings, Inc. | $1.37B | Small cap | +9.23% |
| P1RG34.SA | Perrigo Company plc | $1.37B | Small cap | −59.77% |
| VITR.ST | Vitrolife AB (publ) | $1.36B | Small cap | −31.27% |
| DRTS | Alpha Tau Medical Ltd. | $1.36B | Small cap | +357.94% |
| CHEMM.CO | ChemoMetec A/S | $1.35B | Small cap | −4.56% |
| UPR.L | Uniphar plc | $1.35B | Small cap | +4.35% |
| MNKD | MannKind Corporation | $1.34B | Small cap | +6.67% |
| PNTG | The Pennant Group, Inc. | $1.34B | Small cap | +55.24% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.52% |
| REG.AX | Regis Healthcare Limited | $1.32B | Small cap | −19.77% |
| AMN | AMN Healthcare Services, Inc. | $1.31B | Small cap | +63.90% |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +17.66% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −41.72% |
| SPI.L | Spire Healthcare Group plc | $1.30B | Small cap | +5.16% |
| CRON | Cronos Group Inc. | $1.29B | Small cap | +35.52% |
| CRON.TO | Cronos Group Inc. | $1.29B | Small cap | +34.72% |
| SPTX | Seaport Therapeutics, Inc. | $1.29B | Small cap | +25.15% |
| AORT | Artivion, Inc. | $1.29B | Small cap | −39.45% |
| NUTX | Nutex Health Inc. | $1.28B | Small cap | +110.14% |
| IMTX | Immatics N.V. | $1.26B | Small cap | +76.67% |
| ODTX | Odyssey Therapeutics, Inc. | $1.26B | Small cap | +59.74% |
| 4544.T | H.U. Group Holdings, Inc. | $1.26B | Small cap | +11.45% |
| RYM.AX | RYM FPO NZX [RYM] | $1.26B | Small cap | −28.42% |
| BIOG-B.ST | BioGaia AB (publ) | $1.25B | Small cap | +14.81% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.24B | Small cap | +217.21% |
| CERT | Certara, Inc. | $1.24B | Small cap | −24.70% |
| PRCT | PROCEPT BioRobotics Corporation | $1.24B | Small cap | −45.05% |
| 2175.T | SMS Co., Ltd. | $1.24B | Small cap | +56.85% |
| SANA | Sana Biotechnology, Inc. | $1.23B | Small cap | +22.39% |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.16% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | $1.22B | Small cap | +34.73% |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +0.47% |
| 6523.T | PHC Holdings Corporation | $1.19B | Small cap | +59.08% |
| 4887.T | Sawai Group Holdings Co., Ltd. | $1.18B | Small cap | −12.23% |
| GDRX | GoodRx Holdings, Inc. | $1.17B | Small cap | −18.24% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +115.43% |
| STAA | STAAR Surgical Company | $1.17B | Small cap | −15.68% |
| USPH | U.S. Physical Therapy, Inc. | $1.15B | Small cap | −7.75% |
| TTALO.HE | Terveystalo Oyj | $1.15B | Small cap | −24.58% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.15B | Small cap | +27.68% |
| SVRA | Savara Inc. | $1.15B | Small cap | +78.34% |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.14B | Small cap | −34.83% |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +4.54% |
| JANX | Janux Therapeutics, Inc. | $1.14B | Small cap | −18.82% |
| T2DH34.SA | Teladoc Health, Inc. | $1.13B | Small cap | −23.05% |
| IVA.PA | Inventiva S.A. | $1.13B | Small cap | −14.58% |
| TDOC | Teladoc Health, Inc. | $1.12B | Small cap | −19.30% |
| SNZ.AX | Summerset Group Holdings Limited | $1.12B | Small cap | −32.53% |
| PHIL.MI | Philogen S.p.A. | $1.12B | Small cap | +2.12% |
| IRMD | IRADIMED CORPORATION | $1.11B | Small cap | +24.31% |
| SPH.WA | Sopharma AD | $1.11B | Small cap | −33.66% |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +7.19% |
| IVA | Inventiva S.A. | $1.11B | Small cap | +0.54% |
| 7476.T | AS ONE Corporation | $1.11B | Small cap | +2.10% |
| KURA | Kura Oncology, Inc. | $1.10B | Small cap | +77.65% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | $1.09B | Small cap | +36.80% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | $1.08B | Small cap | −0.90% |
| 006280.KS | GC Biopharma Corp. | $1.06B | Small cap | −1.88% |
| AVTX | Avalo Therapeutics, Inc. | $1.06B | Small cap | +110.00% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $1.04B | Small cap | +107.08% |
| CADL | Candel Therapeutics, Inc. | $1.04B | Small cap | +138.18% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −47.18% |
| QDEL | QuidelOrtho Corporation | $1.03B | Small cap | −45.57% |
| GUBRA.CO | Gubra A/S | $1.03B | Small cap | −2.92% |
| GXI.DE | Gerresheimer AG | $1.03B | Small cap | −33.73% |
| MEDCL.PA | MedinCell S.A. | $1.03B | Small cap | +40.14% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +48.57% |
| CLYM | Climb Bio Inc | $1.02B | Small cap | +619.35% |
| CSTL | Castle Biosciences, Inc. | $1.02B | Small cap | +70.15% |
| PCRX | Pacira BioSciences, Inc. | $1.00B | Small cap | +0.67% |
| 7730.T | Mani, Inc. | $997.86M | Small cap | +32.50% |
| 069620.KS | Daewoong Pharmaceutical Co., Ltd | $997.09M | Small cap | −10.28% |
| GERN | Geron Corporation | $995.83M | Small cap | +9.15% |
| SLDB | Solid Biosciences Inc. | $982.18M | Small cap | +76.61% |
| DSGN | Design Therapeutics, Inc. | $981.28M | Small cap | +201.54% |
| ANNX | Annexon, Inc. | $976.33M | Small cap | +139.53% |
| ARDX | Ardelyx, Inc. | $975.95M | Small cap | −37.62% |
| IMMX | Immix Biopharma, Inc. | $968.90M | Small cap | +589.05% |
| EUZ.DE | Eckert & Ziegler SE | $963.05M | Small cap | −23.06% |
| BVS | Bioventus Inc. | $961.74M | Small cap | +89.25% |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | $958.89M | Small cap | +10.48% |
| VETO.PA | Vetoquinol SA | $958.31M | Small cap | −6.50% |
| OLMA | Olema Pharmaceuticals, Inc. | $954.60M | Small cap | +95.17% |
| HELP | Cybin D/B/A Helus Pharma | $951.24M | Small cap | +92.90% |
| DBVT | DBV Technologies S.A. | $940.80M | Small cap | +52.91% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $934.98M | Small cap | −26.32% |
| NEU.WA | NEUCA S.A. | $930.51M | Small cap | +17.99% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $928.98M | Small cap | +60.46% |
| ACRS | Aclaris Therapeutics, Inc. | $928.83M | Small cap | +263.06% |
| DBV.PA | DBV Technologies S.A. | $928.30M | Small cap | +54.11% |
| 3046.T | JINS HOLDINGS Inc. | $921.19M | Small cap | −21.01% |
| CBLL | CeriBell, Inc. | $919.16M | Small cap | +109.35% |
| PHN.MI | Pharmanutra S.p.A. | $911.23M | Small cap | +71.93% |
| B2RK34.SA | Bruker Corporation | $906.52M | Small cap | +63.27% |
| 4587.T | PeptiDream Inc. | $902.75M | Small cap | −28.26% |
| SGP | SpyGlass Pharma, Inc. | $889.72M | Small cap | +0.76% |
| SYNSAM.ST | Synsam AB (publ) | $889.34M | Small cap | +9.18% |
| 7780.T | Menicon Co., Ltd. | $887.42M | Small cap | +57.22% |
| ANL | Adlai Nortye Ltd. | $884.83M | Small cap | +737.80% |
| TBPH | Theravance Biopharma, Inc. | $883.14M | Small cap | +23.45% |
| MCAP.ST | MedCap AB (publ) | $878.41M | Small cap | −8.86% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +97.74% |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +10.83% |
| SIBN | SI-BONE, Inc. | $866.59M | Small cap | +21.74% |
| AVR | Anteris Technologies Global Corp. | $865.37M | Small cap | +140.27% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +14.75% |
| INMD | InMode Ltd. | $864.89M | Small cap | +3.16% |
| AVR.AX | Anteris Technologies Global Corp. | $863.83M | Small cap | +102.52% |
| 4694.T | BML, Inc. | $862.01M | Small cap | +7.64% |
| DYVOX.ST | Dynavox Group AB (publ) | $860.56M | Small cap | −39.04% |
| SFL.MI | Safilo Group S.p.A. | $856.14M | Small cap | +24.24% |
| COLL | Collegium Pharmaceutical, Inc. | $851.55M | Small cap | −29.15% |
| OXB.L | Oxford Biomedica plc | $850.70M | Small cap | −8.62% |
| FDMT | 4D Molecular Therapeutics, Inc. | $850.21M | Small cap | +133.23% |
| SLN | Silence Therapeutics plc | $849.65M | Small cap | +170.16% |
| AHG | Akso Health Group | $843.17M | Small cap | −44.40% |
| HSTM | HealthStream, Inc. | $841.53M | Small cap | +4.49% |
| GNFT.PA | Genfit S.A. | $836.50M | Small cap | +293.99% |
| AMS.L | Advanced Medical Solutions Group plc | $835.93M | Small cap | +37.58% |
| PHAR | Pharming Group N.V. | $833.06M | Small cap | −19.75% |
| APOTEA.ST | Apotea AB | $828.96M | Small cap | −29.63% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $819.46M | Small cap | +47.91% |
| ARJO-B.ST | Arjo AB (publ) | $817.68M | Small cap | −17.06% |
| NGNE | Neurogene Inc. | $817.26M | Small cap | +104.40% |
| ACHV | Achieve Life Sciences, Inc. | $817.05M | Small cap | +146.83% |
| AURA | Aura Biosciences, Inc. | $810.97M | Small cap | +19.94% |
| WELL.TO | WELL Health Technologies Corp. | $802.96M | Small cap | −10.70% |
| EIQ.AX | Echo IQ Limited | $795.46M | Small cap | +653.66% |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +710.87% |
| SNT.WA | Synektik Spólka Akcyjna | $783.39M | Small cap | +53.56% |
| DRUG | Bright Minds Biosciences Inc. | $779.96M | Small cap | +90.62% |
| VREX | Varex Imaging Corporation | $779.74M | Small cap | +62.28% |
| NVCT | Nuvectis Pharma, Inc. | $777.72M | Small cap | +298.92% |
| UU8.F | Neurogene Inc. | $773.41M | Small cap | +157.60% |
| 001067.KS | JW Pharmaceutical Corporation | $766.24M | Small cap | −21.42% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −3.50% |
| ALLO | Allogene Therapeutics, Inc. | $749.72M | Small cap | +87.07% |
| MNPR | Monopar Therapeutics Inc. | $747.47M | Small cap | +264.30% |
| AHCO | AdaptHealth Corp. | $745.58M | Small cap | −40.63% |
| TECX | Tectonic Therapeutic, Inc. | $737.21M | Small cap | +53.48% |
| SOPH | SOPHiA GENETICS SA | $736.36M | Small cap | +150.72% |
| 4534.T | Mochida Pharmaceutical Co., Ltd. | $735.78M | Small cap | +8.68% |
| CTMX | CytomX Therapeutics, Inc. | $734.32M | Small cap | +68.50% |
| D2OC34.SA | Doximity, Inc. | $734.04M | Small cap | −64.74% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $725.40M | Small cap | +245.67% |
| DHT-UN.TO | DRI Healthcare Trust | $723.54M | Small cap | +28.36% |
| OCS | Oculis Holding AG | $719.64M | Small cap | −27.15% |
| ASMB | Assembly Biosciences, Inc. | $718.32M | Small cap | +32.72% |
| 4588.T | Oncolys BioPharma Inc. | $716.01M | Small cap | +526.71% |
| ZVRA | Zevra Therapeutics, Inc. | $714.98M | Small cap | +28.63% |
| PHAT | Phathom Pharmaceuticals, Inc. | $711.93M | Small cap | −25.15% |
| PHR | Phreesia, Inc. | $711.64M | Small cap | −62.09% |
| SSII | SS Innovations International, Inc. | $711.37M | Small cap | −49.14% |
| XOMA | XOMA Royalty Corp | $710.16M | Small cap | +18.95% |
| 9267.T | Genky DrugStores Co., Ltd. | $706.67M | Small cap | −19.42% |
| C2RS34.SA | CRISPR Therapeutics AG | $704.20M | Small cap | −0.08% |
| BHVN34.SA | BIOHAVEN LTDDRN | $694.78M | Small cap | −18.03% |
| 7575.T | Japan Lifeline Co., Ltd. | $694.70M | Small cap | +12.56% |
| GUD.TO | Knight Therapeutics Inc. | $692.32M | Small cap | +49.08% |
| PROK | ProKidney Corp. | $690.59M | Small cap | −26.38% |
| AGMB | AgomAb Therapeutics NV | $690.46M | Small cap | −4.30% |
| DHT-U.TO | DRI Healthcare Trust | $690.34M | Small cap | +27.68% |
| GMRS | GMR Solutions Inc. | $686.08M | Small cap | −9.16% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.